Immunic, Inc. Reports Second Quarter 2025 Financial Results and Provides Corporate Update

Go back to Immunic, Inc. Reports Second Quarter 2025 Financial Results and Provides Corporate Update

Immunic Inc. (IMUX) Misses Q2 EPS by 3c

August 7, 2025 6:33 AM EDT

Immunic Inc. (NASDAQ: IMUX) reported Q2 EPS of ($0.20), $0.03 worse than the analyst estimate of ($0.17).

For earnings history and earnings-related data on Immunic Inc. (IMUX) click here.

... More